research use only

PD0325901 (Mirdametinib) MEK inhibitor

Cat.No.S1036

Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM in cell-free assays, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 2.
Jump to

Quality Control

Batch: Purity: 99.99%
99.99

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 96 mg/mL (199.09 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 96 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about PD0325901 (Mirdametinib) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Step 1: Select a research area to find working concentrations, or search directly for a cell line

Read more about PD0325901 (Mirdametinib) working concentrations for cell culture treatment

Working Concentrations for Animal Model Treatment

Step 1: Select a research area to find working concentrations, or search directly for an animal type

×

Mechanism of Action

Information PD0325901 (Mirdametinib) is a potent, selective MEK1/2 inhibitor. It affects the MAPK/ERK signaling pathway by preventing ERK1/2 phosphorylation, effectively inhibiting cancer cell proliferation, migration, and inflammation, while promoting stem cell pluripotency.

Read more about PD0325901 (Mirdametinib) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about PD0325901 (Mirdametinib) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 482.19 Formula

C16H14F3IN2O4

Storage (From the date of receipt)
CAS No. 391210-10-9 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about PD0325901 (Mirdametinib)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
Whether it interacts with other targets other than MEK?

Answer:
It has very high selectivity to MEK. In addition, this compound can also inhibits VEGF activity according to the reference: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713590/